Andres J Acosta

29PUBLICATIONS
50CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedBehavioural epidemiologyPharmacogenomicsMedical biochemistry - lipidsInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 24, 2026
Publisher Correction: Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial.

|Jun 15, 2026
Sex, Not Age, Predicts Weight Loss Outcomes With Tirzepatide: A Retrospective Analysis.

|Jun 05, 2026
Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial.

|Apr 06, 2026
Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Literature Review on Pathophysiology and Treatment.

Michael Romanos, Juan M Garcia Cordova, Jose Villamarin

|Jan 28, 2026
Obesity Phenotyping in Children and Adolescents: Next Steps Towards Precision Medicine in Pediatric Obesity.

Leslie Saba, Andres J Acosta, Aaron S Kelly

|Jan 21, 2026
Addition of Phentermine-Topiramate to a Digitally Enhanced Lifestyle Intervention: A Double-Blind Randomized Clinical Trial.

Alejandro Campos, Wissam Ghusn, Lizeth Cifuentes

Pageof 5

Frequent Collaborators

10 joint publications

Michael Camilleri

7 joint publications

Maria Daniela Hurtado A

6 joint publications

Lizeth Cifuentes

5 joint publications

Alejandro Campos